NJ ACTS
OPCA supports NJIT’s partnership with NJ ACTS to advance research that serves public health and community impact.
Through stategic collaborations, OPCA helps align academic efforts with civic engagement and statewide priorities.
New Jersey Alliance for Clinical and Translational Science (NJ ACTS)
NJIT is proud to participate in the New Jersey Alliance for Clinical and Translational Science (NJ ACTS), a tri‑institutional initiative involving NJIT, Rutgers University and Princeton University. Funded through the NIH’s CTSA program, NJ ACTS advances the translation of research discoveries into practical health innovations across New Jersey.
Bridging Research and Public Impact
As part of NJ ACTS, NJIT works collaboratively with partner institutions and health systems to support pilot projects, training programs, and infrastructure development for clinical and translational science. By participating in funding opportunities like the Pilot Grants Program and fellowship training, NJIT contributes to the movement that accelerates scientific breakthroughs into improvements in healthcare and population wellbeing.
The Office of Public and Community Affairs helps guide NJIT’s involvement in NJ ACTS by elevating these collaborative initiatives in alignment with the university’s public engagement mission. This ensures that NJIT’s role within the alliance supports regional health priorities and civic engagement